Enanta Pharmaceuticals
ENTA
#8599
Rank
HK$1.18 B
Marketcap
HK$55.58
Share price
-4.80%
Change (1 day)
-46.40%
Change (1 year)

P/S ratio for Enanta Pharmaceuticals (ENTA)

P/S ratio as of February 2025 (TTM): 2.31

According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.21. At the end of 2024 the company had a P/S ratio of 3.15.

P/S ratio history for Enanta Pharmaceuticals from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20243.1516.97%
20232.69-77.16%
202211.8-28.54%
202116.598.3%
20208.3227.67%
20196.5112.81%
20185.77-32.86%
20178.60-32.26%
201612.7169.68%
20154.71-38.15%
20147.61-92.1%
201396.3

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.16 166.96%๐Ÿ‡บ๐Ÿ‡ธ USA
4.31 86.74%๐Ÿ‡บ๐Ÿ‡ธ USA
11.1 382.92%๐Ÿ‡บ๐Ÿ‡ธ USA
3.31 43.39%๐Ÿ‡บ๐Ÿ‡ธ USA
2.33 1.10%๐Ÿ‡บ๐Ÿ‡ธ USA
4.19 81.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland